Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Toshiaki, Ihara"'
Autor:
Kazutoyo Asada, Hajime Kamiya, Shigeru Suga, Mizuho Nagao, Ryoji Ichimi, Takao Fujisawa, Masakazu Umemoto, Takaaki Tanaka, Hiroaki Ito, Shigeki Tanaka, Masaru Ido, Koki Taniguchi, Toshiaki Ihara, Takashi Nakano
Publikováno v:
Western Pacific Surveillance and Response, Vol 7, Iss 4, Pp 21-36 (2016)
Background: Rotavirus vaccines were introduced in Japan in November 2011. We evaluated the subsequent reduction of the health-care burden of rotavirus gastroenteritis. Methods: We conducted active surveillance for rotavirus gastroenteritis among c
Externí odkaz:
https://doaj.org/article/a8eb04b7f8c24df5a065ffaea1b20993
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 4, Pp 703-706 (2016)
Recently, a new paramyxovirus closely related to human mumps virus (MuV) was detected in bats. We generated recombinant MuVs carrying either or both of the fusion and hemagglutinin-neuraminidase bat virus glycoproteins. These viruses showed replicati
Externí odkaz:
https://doaj.org/article/d3de2758d56042168f43b672145a8110
Autor:
Koa Hosoki, Takao Fujisawa, Akihiko Hashiguchi, Mizuho Nagao, Yukiko Hiraguchi, Reiko Tokuda, Takashi Nakano, Hiroyuki Nunoi, Toshiaki Ihara
Publikováno v:
Allergology International, Vol 61, Iss 3, Pp 507-509 (2012)
Externí odkaz:
https://doaj.org/article/c8eaf4d523084667a74324c2315fd0b9
Publikováno v:
Vaccine. 34:4079-4082
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8156f23580d0d84fbc4cf915e30687db
https://doi.org/10.1016/j.vaccine.2016.06.030
https://doi.org/10.1016/j.vaccine.2016.06.030
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 4, Pp 703-706 (2016)
Emerging Infectious Diseases
Emerging Infectious Diseases
Recently, a new paramyxovirus closely related to human mumps virus (MuV) was detected in bats. We generated recombinant MuVs carrying either or both of the fusion and hemagglutinin-neuraminidase bat virus glycoproteins. These viruses showed replicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6621998337bd61c2ae12ec97bb846fab
https://doi.org/10.3201/eid2204.151116
https://doi.org/10.3201/eid2204.151116
Publikováno v:
Journal of Allergy and Clinical Immunology. 137(3):861-867
Background Influenza vaccines produced in embryonated eggs might pose a risk to patients with egg allergy. However, patients experiencing influenza vaccine–associated anaphylaxis (IVA) do not always have egg allergy. In the 2011-2012 season, an unu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db0e41fc44244eda92e0ec9617f6d3cf
Autor:
Michael S. Niederman, Shigeru Suga, Kiyoyuki Tsutsui, Mizuho Nagao, Takao Fujisawa, Takaya Maruyama, Kiyosu Taniguchi, Haruna Nakamura, Toshiaki Ihara
Publikováno v:
Chest. 149:526-534
Background In Japan, the routine use of early antiviral therapy for patients with influenza is standard. Methods This multicenter prospective cohort evaluation of hospitalized patients with laboratory-confirmed influenza identified prognostic factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::923976ea8cd7aa5d8a571e95b089d38c
https://doi.org/10.1378/chest.14-2768
https://doi.org/10.1378/chest.14-2768
Autor:
Bin Chang, Shunji Takakura, Toshiaki Ihara, Satoshi Ichiyama, Miki Nagao, Taro Noguchi, Yasufumi Matsumura, Yutaka Ito, Makoto Ohnishi, Masaki Yamamoto, Satoshi Nakano, Takao Fujisawa, Shigeru Suga
Publikováno v:
Vaccine. 34:67-76
Pneumococcal infection in children is a major public health problem worldwide, including in Japan. The pneumococcal conjugate vaccine 7 (PCV7) was licensed for use in Japan in 2010 followed by PCV13 in 2013. This report includes the results of a nati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf577c7212362194c91ddfb25ea56f59
https://doi.org/10.1016/j.vaccine.2015.11.015
https://doi.org/10.1016/j.vaccine.2015.11.015
Autor:
Toshiaki Ihara, Tatsuro Nobutoki
Publikováno v:
Medical Hypotheses. 85:842-845
Spinal muscular atrophy type I (SMA-I) is characterized by progressive muscle weakness with onset in early infancy, usually resulting in mortality before two years of age. However, the processes underlying the pathophysiological progression of the di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea2fe26fd9ff2fbb733415c7a244fabc
https://doi.org/10.1016/j.mehy.2015.09.028
https://doi.org/10.1016/j.mehy.2015.09.028
Publikováno v:
Vaccine. 33:6049-6053
Objective The purpose of this study was to determine the risk of aseptic meningitis after mumps vaccination in younger children compared with older children. Methods This prospective cohort study included a total of 21,465 children under 18 years of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9723ace207c16be1971f60c807e1caa
https://doi.org/10.1016/j.vaccine.2015.09.068
https://doi.org/10.1016/j.vaccine.2015.09.068